This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Daoqian Chen: Innovator in Thyroid Hormone Research
Introduction
Daoqian Chen is a prominent inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target thyroid hormone receptors. His innovative work has the potential to impact the treatment of various diseases.
Latest Patents
Daoqian Chen holds a patent for a chemical compound that acts as a thyroid hormone beta receptor agonist. This patent, titled "Chemical compound as thyroid hormone beta receptor agonist and use thereof," describes a pharmaceutical composition that includes the chemical compound. The compound can be utilized in the preparation of drugs aimed at preventing, treating, or mitigating diseases mediated by the agonistic thyroid hormone β receptor. Notably, it is particularly relevant for the treatment of non-alcoholic fatty liver diseases. He has 1 patent to his name.
Career Highlights
Daoqian Chen is currently employed at Sunshine Lake Pharma Co., Ltd. His role at the company allows him to engage in cutting-edge research and development in the pharmaceutical sector. His work is characterized by a commitment to advancing medical science through innovative solutions.
Collaborations
Daoqian Chen collaborates with esteemed colleagues, including Zheng Gu and Jianhao Li. These partnerships enhance the research and development efforts at Sunshine Lake Pharma Co., Ltd., fostering an environment of innovation and discovery.
Conclusion
Daoqian Chen's contributions to thyroid hormone research exemplify the impact of innovative thinking in the pharmaceutical industry. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in the treatment of liver diseases.